EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares of Trinity Biotech plc dated May 3, 2019, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

Dated: May 3, 2019

WHITEFORT CAPITAL MASTER FUND, LP

By: Whitefort Capital GP, LLC, its general partner

By: /s/ David Salanic
David Salanic, Co-Managing Partner

By: /s/ Joseph Kaplan
Joseph Kaplan, Co-Managing Partner

WHITEFORT CAPITAL MANAGEMENT, LP

By:        /s/ David Salanic

              David Salanic, Co-Managing Partner

By:        /s/ Joseph Kaplan

              Joseph Kaplan, Co-Managing Partner

/s/ David SalanicDAVID SALANIC

/s/ Joseph Kaplan

JOSEPH KAPLAN